Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMASS2: Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke
NCT07365475Phase 2Not yet recruiting
- Sponsor
- Tianjin Huanhu Hospital
- Start
- Jan 2026
- Primary completion
- Jun 2028
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of albumin (human) in ischemic stroke, sponsored by Tianjin Huanhu Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
albumin (human)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07365475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07365475.